25 May 2013
Keywords: antigenics, hsp, technology, heading, success, although, may
Article | 16 April 1998
Although it may sound ambitious, Antigenics, a privately-held USbiopharmaceutical company located in New York, says that it intends to develop ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.